Best Karen P, Yelland Lisa N, Collins Carmel T, McPhee Andrew J, Rogers Geraint B, Choo Jocelyn, Gibson Robert A, Murguia-Peniche Teresa, Varghese Jojy, Cooper Timothy R, Makrides Maria
Women and Kids Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.
Front Pediatr. 2023 May 2;11:1146089. doi: 10.3389/fped.2023.1146089. eCollection 2023.
We aimed to compare the effects of nutrient-enriched formula with standard term formula on rate of body weight gain of late preterm infants appropriately grown for gestational age.
A multi-center, randomized, controlled trial. Late preterm infants (34-37 weeks' gestation), with weight appropriate for gestational age (AGA), were randomized to nutrient enriched formula (NEF) with increased calories (22 kcal/30 ml) from protein, added bovine milk fat globule membrane, vitamin D and butyrate or standard term formula 20 kcal/30 ml (STF). Breastfed term infants were enrolled as an observational reference group (BFR). Primary outcome was rate of body weight gain from enrollment to 120 days corrected age (d/CA). Planned sample size was 100 infants per group. Secondary outcomes included body composition, weight, head circumference and length gain, and medically confirmed adverse events to 365 d/CA.
The trial was terminated early due to recruitment challenges and sample size was substantially reduced. 40 infants were randomized to NEF ( = 22) and STF ( = 18). 39 infants were enrolled in the BFR group. At 120 d/CA there was no evidence of a difference in weight gain between randomized groups (mean difference 1.77 g/day, 95% CI, -1.63 to 5.18, = 0.31). Secondary outcomes showed a significant reduction in risk of infectious illness in the NEF group at 120 d/CA [relative risk 0.37 (95% CI, 0.16-0.85), = 0.02].
We saw no difference in rate of body weight gain between AGA late preterm infants fed NEF compared to STF. Results should be interpreted with caution due to small sample size.
The Australia New Zealand Clinical Trials Registry (ACTRN 12618000092291). "mailto:maria.makrides@sahmri.com" maria.makrides@sahmri.com.
我们旨在比较营养强化配方奶粉与标准足月儿配方奶粉对适于胎龄的晚期早产儿体重增加速率的影响。
一项多中心、随机对照试验。晚期早产儿(妊娠34 - 37周),体重适于胎龄(AGA),被随机分为营养强化配方奶粉(NEF)组,其每30毫升含热量增加至22千卡,热量来自蛋白质、添加的牛乳脂肪球膜、维生素D和丁酸盐,或标准足月儿配方奶粉(STF)组,每30毫升含热量20千卡。母乳喂养的足月儿作为观察参考组(BFR)。主要结局是从入组至矫正年龄120天的体重增加速率(每天克数/d/CA)。计划每组样本量为100名婴儿。次要结局包括身体组成、体重、头围和身长增加,以及至365 d/CA经医学确认的不良事件。
由于招募困难,试验提前终止,样本量大幅减少。40名婴儿被随机分为NEF组(n = 22)和STF组(n = 18)。39名婴儿纳入BFR组。在矫正年龄120天时,随机分组的两组间体重增加无差异的证据(平均差异1.77克/天,95%可信区间,-1.63至5.18,P = 0.31)。次要结局显示,在矫正年龄120天时,NEF组感染性疾病风险显著降低[相对风险0.37(95%可信区间,0.16 - 0.85),P = 0.02]。
与STF相比,喂养NEF的AGA晚期早产儿体重增加速率无差异。由于样本量小,结果应谨慎解读。
澳大利亚新西兰临床试验注册中心(ACTRN 12618000092291)。“mailto:maria.makrides@sahmri.com” maria.makrides@sahmri.com 。